Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment - ScienceDirect
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Kappa Opiate Receptor - an overview | ScienceDirect Topics
IJMS | Free Full-Text | Distinct Effects of Nalmefene on Dopamine Uptake Rates and Kappa Opioid Receptor Activity in the Nucleus Accumbens Following Chronic Intermittent Ethanol Exposure
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Activation of kappa opioid receptor (KOR) signaling increases... | Download Scientific Diagram
Opioids in cancer: The κ‑opioid receptor (Review)
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - ScienceDirect
μ-Opposing actions of the κ-opioid receptor: Trends in Pharmacological Sciences
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
Structure of the human κ-opioid receptor in complex with JDTic | Nature
Opioid receptors | Introduction | BPS/IUPHAR Guide to PHARMACOLOGY
Frontiers | Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain
Pathways and Receptors – Opioid Peptides
Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion | Semantic Scholar
Opioid Receptor | kappa, mu Opioid Receptor
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway | Cell Communication and Signaling | Full Text
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
Kappa Opioid Receptor Structure Revealed, A Potential Milestone in Medication Development | National Institute on Drug Abuse (NIDA)
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
